In NB4 cancer cells, the combination treatment led to a stronger down-regulation of SPI1 in the cytoplasmic and nuclear fractions and a more pronounced down-regulation of CEBPE in the cytoplasmic fraction. The gene discussed is SPI1; the disease is cancer.